(Q35564937)

8 August 2017

1 reference

title

Bariatric surgery: prevalence, predictors, and mechanisms of diabetes remission (English)

1 reference

8 August 2017

0 references

George Argyropoulos

1

1 reference

8 August 2017

publication date

1 April 2015

1 reference

8 August 2017

published in

Current diabetes report

1 reference

8 August 2017

volume

15

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

15

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-015-0590-9

8 August 2017

exact match

0 references

cites work

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Economic costs of diabetes in the U.S. In 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

How do we define cure of diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Association of an intensive lifestyle intervention with remission of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell Function in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Psychological and social aspects of the surgical treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

The role of gastric surgery in the multidisciplinary management of severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Bariatric surgery versus conventional medical therapy for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Diabetes: the search for mechanisms underlying bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Inhibition of growth hormone signaling by the fasting-induced hormone FGF21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

The enzymes, regulation, and genetics of bile acid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Bile acids: regulation of synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

FXR, a multipurpose nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Roles of FGF19 in liver metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Modulation of fibroblast growth factor 19 expression by bile acids, meal replacement and energy drinks, milk, and coffee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Fundamentals of FGF19 & FGF21 action in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Endocrine fibroblast growth factors 15/19 and 21: from feast to famine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

FGF-21 as a novel metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Gene expression profiling in subcutaneous, visceral and epigastric adipose tissues of patients with extreme obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Improvement in hepatic insulin sensitivity after Roux-en-Y gastric bypass in a rat model of obesity is partially mediated via hypothalamic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Crosstalk between gastrointestinal neurons and the brain in the control of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Food reward functions as affected by obesity and bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Food reward, hyperphagia, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Selective reduction in neural responses to high calorie foods following gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Cooperation between brain and islet in glucose homeostasis and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Neuroscience. The fat-brain axis enters a new dimension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Central nervous system control of food intake and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

CNS GLP-1 regulation of peripheral glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

The fasting polypeptide FGF21 can enter brain from blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Fibroblast growth factor 19 entry into brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

The importance of the gut microbiota after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

The human gut microbiome: a review of the effect of obesity and surgically induced weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Increased hepatic insulin clearance after Roux-en-Y gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Surgical approaches for the prevention and treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Bariatric surgery: a cure for diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0590-9

Standards of medical care in diabetes--2012

21 January 2018

1 reference

12 December 2020

Outcomes of Roux-en-Y gastric bypass surgery for severely obese patients with type 1 diabetes: a case series report

1 reference

12 December 2020

Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice.

1 reference

12 December 2020

Central nervous system control of food intake

1 reference

12 December 2020

FGF19 action in the brain induces insulin-independent glucose lowering

1 reference

12 December 2020

Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans.

1 reference

12 December 2020

Brain pathways controlling food intake and body weight.

1 reference

12 December 2020

Preoperative use of incretins is associated with increased diabetes remission after RYGB surgery among patients taking insulin: a retrospective cohort analysis

1 reference

12 December 2020

Metabolic surgery, weight regain and diabetes re-emergence

1 reference

12 December 2020

Intra-uterine microbial colonization and occurrence of endometritis in women with endometriosis†.

1 reference

12 December 2020

Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity

1 reference

12 December 2020

Microbial modulation of insulin sensitivity

1 reference

12 December 2020

Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity

1 reference

12 December 2020

GLP-1 plays a limited role in improved glycemia shortly after Roux-en-Y gastric bypass: a comparison with intensive lifestyle modification

1 reference

12 December 2020

DiaRem score: external validation

1 reference

12 December 2020

Gastric bariatric operation in insulin-treated adults

1 reference

12 December 2020

Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery

1 reference

12 December 2020

10.1007/S11892-015-0590-9

Identifiers

DOI

1 reference

8 August 2017

1 reference